SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-091945
Filing Date
2024-04-10
Accepted
2024-04-10 16:30:56
Documents
13
Period of Report
2024-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K d818064d8k.htm   iXBRL 8-K 24794
  Complete submission text file 0001193125-24-091945.txt   146659

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA etnb-20240404.xsd EX-101.SCH 2844
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20240404_lab.xml EX-101.LAB 17994
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20240404_pre.xml EX-101.PRE 11257
16 EXTRACTED XBRL INSTANCE DOCUMENT d818064d8k_htm.xml XML 3633
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 24836188
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)